Neurogene (NGNE) Return on Sales (2018 - 2025)
Historic Return on Sales for Neurogene (NGNE) over the last 6 years, with Q3 2025 value amounting to 1084.71%.
- Neurogene's Return on Sales rose 13014900.0% to 1084.71% in Q3 2025 from the same period last year, while for Sep 2025 it was 1084.71%, marking a year-over-year increase of 13014900.0%. This contributed to the annual value of 81.84% for FY2024, which is N/A changed from last year.
- Latest data reveals that Neurogene reported Return on Sales of 1084.71% as of Q3 2025, which was up 13014900.0% from 1075.41% recorded in Q2 2025.
- In the past 5 years, Neurogene's Return on Sales registered a high of 17553.33% during Q4 2023, and its lowest value of 234.38% during Q4 2024.
- Over the past 3 years, Neurogene's median Return on Sales value was 1075.41% (recorded in 2025), while the average stood at 4052.61%.
- Its Return on Sales has fluctuated over the past 5 years, first plummeted by -177877200bps in 2024, then soared by 13014900bps in 2025.
- Neurogene's Return on Sales (Quarter) stood at 17553.33% in 2023, then plummeted by -101bps to 234.38% in 2024, then surged by 563bps to 1084.71% in 2025.
- Its Return on Sales was 1084.71% in Q3 2025, compared to 1075.41% in Q2 2025 and 284.91% in Q1 2025.